secwatch / observer
8-K filed Jun 20, 2025 23:59 UTC CIK 0001741830
m_and_a confidence high sentiment neutral materiality 0.85

Kronos Bio acquired by Concentra Biosciences for $0.57/share plus CVR; delisting effective

Kronos Bio, Inc.

item 2.01item 3.01item 3.03item 5.01item 5.02item 5.03item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Kevin Tang

Chief Executive Officer
Kronos Bio, Inc.
Effective
2025-06-20
Filed
Jun 20, 2025 23:59 UTC
The executive officers of Merger Sub immediately prior to the Effective Time were: (i) Mr. Tang, Chief Executive Officer
Departed

Roger Dansey

Director
Kronos Bio, Inc.
Effective
2025-06-20
Filed
Jun 20, 2025 23:59 UTC
at the Effective Time, each of Arie Belldegrun, M.D., Norbert Bischofberger, Ph.D., Roshawn Blunt, Roger Dansey, M.D., Joshua Kazam, Elena Ridloff, CFA, Katherine Vega Stultz, David M. Tanen and Taiyin Yang, Ph.D. resigned from the board of directors of the Company
Departed

Katherine Vega Stultz

Director
Kronos Bio, Inc.
Effective
2025-06-20
Filed
Jun 20, 2025 23:59 UTC
at the Effective Time, each of Arie Belldegrun, M.D., Norbert Bischofberger, Ph.D., Roshawn Blunt, Roger Dansey, M.D., Joshua Kazam, Elena Ridloff, CFA, Katherine Vega Stultz, David M. Tanen and Taiyin Yang, Ph.D. resigned from the board of directors of the Company
Departed

Taiyin Yang

Director
Kronos Bio, Inc.
Effective
2025-06-20
Filed
Jun 20, 2025 23:59 UTC
at the Effective Time, each of Arie Belldegrun, M.D., Norbert Bischofberger, Ph.D., Roshawn Blunt, Roger Dansey, M.D., Joshua Kazam, Elena Ridloff, CFA, Katherine Vega Stultz, David M. Tanen and Taiyin Yang, Ph.D. resigned from the board of directors of the Company
Departed

Joshua Kazam

Director
Kronos Bio, Inc.
Effective
2025-06-20
Filed
Jun 20, 2025 23:59 UTC
at the Effective Time, each of Arie Belldegrun, M.D., Norbert Bischofberger, Ph.D., Roshawn Blunt, Roger Dansey, M.D., Joshua Kazam, Elena Ridloff, CFA, Katherine Vega Stultz, David M. Tanen and Taiyin Yang, Ph.D. resigned from the board of directors of the Company
Departed

Norbert Bischofberger

Director
Kronos Bio, Inc.
Effective
2025-06-20
Filed
Jun 20, 2025 23:59 UTC
at the Effective Time, each of Arie Belldegrun, M.D., Norbert Bischofberger, Ph.D., Roshawn Blunt, Roger Dansey, M.D., Joshua Kazam, Elena Ridloff, CFA, Katherine Vega Stultz, David M. Tanen and Taiyin Yang, Ph.D. resigned from the board of directors of the Company
Departed

David M. Tanen

Director
Kronos Bio, Inc.
Effective
2025-06-20
Filed
Jun 20, 2025 23:59 UTC
at the Effective Time, each of Arie Belldegrun, M.D., Norbert Bischofberger, Ph.D., Roshawn Blunt, Roger Dansey, M.D., Joshua Kazam, Elena Ridloff, CFA, Katherine Vega Stultz, David M. Tanen and Taiyin Yang, Ph.D. resigned from the board of directors of the Company
Departed

Elena Ridloff

Director
Kronos Bio, Inc.
Effective
2025-06-20
Filed
Jun 20, 2025 23:59 UTC
at the Effective Time, each of Arie Belldegrun, M.D., Norbert Bischofberger, Ph.D., Roshawn Blunt, Roger Dansey, M.D., Joshua Kazam, Elena Ridloff, CFA, Katherine Vega Stultz, David M. Tanen and Taiyin Yang, Ph.D. resigned from the board of directors of the Company
Departed

Deborah Knobelman

Other Named Officer
Kronos Bio, Inc.
Effective
2025-06-20
Filed
Jun 20, 2025 23:59 UTC
Dr. Deborah Knobelman resigned from her position as an officer of the Company.
Departed

Roshawn Blunt

Director
Kronos Bio, Inc.
Effective
2025-06-20
Filed
Jun 20, 2025 23:59 UTC
at the Effective Time, each of Arie Belldegrun, M.D., Norbert Bischofberger, Ph.D., Roshawn Blunt, Roger Dansey, M.D., Joshua Kazam, Elena Ridloff, CFA, Katherine Vega Stultz, David M. Tanen and Taiyin Yang, Ph.D. resigned from the board of directors of the Company
Appointed

Kevin Tang

Director
Kronos Bio, Inc.
Effective
2025-06-20
Filed
Jun 20, 2025 23:59 UTC
The sole director of Merger Sub immediately prior to the Effective Time was Kevin Tang.
Departed

Arie Belldegrun

Director
Kronos Bio, Inc.
Effective
2025-06-20
Filed
Jun 20, 2025 23:59 UTC
at the Effective Time, each of Arie Belldegrun, M.D., Norbert Bischofberger, Ph.D., Roshawn Blunt, Roger Dansey, M.D., Joshua Kazam, Elena Ridloff, CFA, Katherine Vega Stultz, David M. Tanen and Taiyin Yang, Ph.D. resigned from the board of directors of the Company
Source: SEC EDGAR
accession 0001213900-25-055915
view filing index on sec.gov
view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.